| Filed On | Filing |
|---|---|
| 31 Oct 2024 |
8-K/A: Results of Operations and Financial Condition
Achieves third quarter revenue growth of 7% as reported and 6% organic, supported by CAG Diagnostics recurring revenue growth of 7% as reported and organic. |
| 23 Oct 2017 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 06 Oct 2017 |
8-K/A: Submission of Matters to a Vote of Security Holders
(d) As previously reported in the Original Form 8-K, in a non-binding advisory vote on the frequency of future say-on-pay votes held at the Annual Meeting, 65,065,303 shares voted for annual votes, 84,157 shares voted for votes every two... |
| 22 Feb 2017 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 16 Feb 2017 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 07 May 2010 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 12 May 2006 |
8-K/A: Departure/Election of Directors or Officers; Compensation
(d) On March 17, 2006, IDEXX Laboratories, Inc. (the “Company”) filed a Current Report on Form 8-K reporting that the Company’s board of directors elected Barry C. Johnson, PhD as a director. At the time of the required filing, the board... |
| 19 May 2005 |
8-K/A: Departure/Election of Directors or Officers; Compensation
(d) On February 23, 2005, IDEXX Laboratories, Inc. (the “Company”) filed a Current Report on Form 8-K reporting that the Company’s board of directors appointed Robert J. Murray as a director. At the time of the required filing, the board... |
| 12 Nov 1998 |
8-K/A: Financial Statements and Exhibits
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Loading...